
20- Physician-Investor Series: David Kaufman, MD (Third Rock Ventures)
03/23/22 • 48 min
Is it important for MDs to consider taking a more prominent role in the process of developing and getting drugs to market, either on the operating side or the investing side? How can we change and fix financial incentives in drug development? In this episode, we answer all these questions and more with our guest, David Kaufman, M.D.
David is a Partner at Third Rock Ventures, a leading healthcare venture firm that specializes in company creation rather than the traditional venture investing model.
David has an MD from Cornell University, and a PHD in immunology and molecular virology from Rockefeller University.
Is it important for MDs to consider taking a more prominent role in the process of developing and getting drugs to market, either on the operating side or the investing side? How can we change and fix financial incentives in drug development? In this episode, we answer all these questions and more with our guest, David Kaufman, M.D.
David is a Partner at Third Rock Ventures, a leading healthcare venture firm that specializes in company creation rather than the traditional venture investing model.
David has an MD from Cornell University, and a PHD in immunology and molecular virology from Rockefeller University.
Previous Episode

19- Physician-Investor Series: Justin Norden, MD (GSR Ventures)
Why is there a mismatch between VC companies and some vulnerable patient populations? Do we need a radical transformation from the ground up of the medical curriculum? Are there any similarities between clinical and athletic training and investing? In this episode, we answer all of these questions and more with our guest, Justin Norden, MD.
Justin is a Partner at GSR Ventures, where he focuses on early-stage investments in digital health, AI/ML in healthcare, and enterprise technology.
Justin received his MD from Stanford University School of Medicine, MBA from the Stanford Graduate School of Business, M.Phil in Computational Biology from the University of Cambridge, and BA in Computer Science from Carleton College.
Next Episode

21- Physician-Entrepreneur Series: Shiv Gaglani (Osmosis.org)
How did Osmosis, the popular health education platform, come about? Why do we need more MDs in spaces like health policy? In this episode, we answer all these questions and more with our guest, Shiv Gaglani.
Shiv is the co-founder and chief executive officer of Osmosis, which makes a popular web- and mobile-learning platform used by more than 3 million medical and allied health professions students and 30+ medical schools.
After graduating magna cum laude from Harvard College in 2010 with degrees in engineering and health policy, Shiv began his MD degree at the Johns Hopkins School of Medicine and earned his MBA from Harvard Business School in 2016.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/physicians-off-the-beaten-path-260206/20-physician-investor-series-david-kaufman-md-third-rock-ventures-30692927"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to 20- physician-investor series: david kaufman, md (third rock ventures) on goodpods" style="width: 225px" /> </a>
Copy